75Health

Main Menu

  • Home
  • About Us
  • Services
    • Electronic Health Records
    • Electronic Medical Records
    • Personal Health Records
    • Practice Management Software
    • EHR and EMR Providers
  • Go back to 75health.com

logo

75Health

  • Home
  • About Us
  • Services
    • Electronic Health Records
    • Electronic Medical Records
    • Personal Health Records
    • Practice Management Software
    • EHR and EMR Providers
  • Go back to 75health.com
Blog
Home›Blog›FDA Approves Cannabidiol for Tuberous Sclerosis Complex.

FDA Approves Cannabidiol for Tuberous Sclerosis Complex.

By 75health
August 4, 2020
276
0

The cannabidiol (CBD) oral solution Epidiolex has been approved by the US Food and Drug Administration (FDA) for the new indication of treatment of seizures associated with tuberous sclerosis complex in patients 1 year of age and older.

75health Signup

The drug was approved by the FDA in 2018 for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, as reported by Medscape Medical News.

This is the only FDA-approved drug that contains a purified drug substance derived from cannabis. It is also the second FDA approval of a drug for the treatment of seizures associated with tuberous sclerosis complex.

CBD is a chemical component of the cannabis sativa plant, but it does not cause intoxication or euphoria (the “high”) that comes from tetrahydrocannabinol (THC), which is the primary psychoactive component of cannabis.

“The FDA continues to believe the drug approval process represents the best way to make new medicines, including any drugs derived from cannabis, available to patients in need of appropriate medical therapy such as the treatment of seizures associated with these rare conditions,” Douglas Throckmorton, MD, deputy center director for regulatory programs in the FDA’s Center for Drug Evaluation and Research, said in an agency press release.

“This paradigm ensures new therapies are safe, effective, and manufactured to a high quality that provides uniform and reliable dosing for patients,” Throckmorton said.

He added that the FDA is committed to supporting research on the potential medical uses of cannabis-derived products.

Rare Genetic Disease

Tuberous sclerosis complex is a rare genetic disease that causes benign tumors to grow in the brain and other parts of the body, such as the eyes, heart, kidneys, lungs, and skin.

It usually affects the central nervous system and can result in a combination of symptoms, including seizures, developmental delay, and behavioral problems. The signs and symptoms of the condition, as well as the severity of symptoms, vary widely. The disease affects about 1 in 6000 individuals.

The effectiveness of Epidiolex in the treatment of seizures associated with tuberous sclerosis complex was established in a randomized, double-blind, placebo-controlled trial in which 148 patients of a total of 224 in the study received the active drug, the FDA notes.

Results showed that for patients treated with CBD, there was a significantly greater reduction in seizure frequency during the treatment period than for patients who received placebo.

This effect was seen within 8 weeks and remained consistent throughout the 16-week treatment period.

The most common side effects that occurred in CBD-treated participants were diarrhea, elevated liver enzyme levels, decreased appetite, sleepiness, fever, and vomiting. Additional side effects that have been reported with the product include liver injury, decreased weight, anemia, and increased creatinine level.

As is true for all drugs that currently treat epilepsy, including Epidiolex, the most serious risks may include an increase in suicidal thoughts and behavior or thoughts of self-harm, the FDA reports.

Patients, their caregivers, and their families should be advised to monitor for any unusual changes in mood or behavior, such as worsening depression or suicidal thoughts or behavior. They should report behaviors of concern immediately to healthcare providers, the agency notes.

75Health getstarted

It also points out that Epidiolex can cause liver injury, of which most cases are generally mild. However, there is a risk for rare but more severe liver injury. More severe liver injury can cause nausea, vomiting, abdominal pain, fatigue, anorexia, jaundice, and/or dark urine.

Source : https://www.medscape.com/viewarticle/935067

 

TagsdoctorElectronic Medical Record ProvidersEMR Providershealthhealth careHospitalMedical
Previous Article

Blood test for a specific tau protein ...

Next Article

‘Apollo 11 Moment’: Two Monoclonal Antibody Trials ...

Related articles More from author

  • Blog

    Advantage of Patient Portal in Personal Health Records.

    March 26, 2021
    By 75health
  • Blog

    No More Misfiled Charts, When Electronic Medical Records Is Here.

    March 31, 2021
    By 75health
  • Blog

    Optimization in Electronic Medical Records Software.

    November 24, 2020
    By 75health
  • Blog

    Brain noise contains unique signature of dream sleep.

    August 10, 2020
    By 75health
  • Blog

    Medication Management Boosts the Usage of E-Prescribing Software.

    March 29, 2021
    By 75health
  • Blog

    Cardiologist Claims Accuracy with Electronic Health Records.

    January 18, 2021
    By 75health

Leave a reply Cancel reply

  • Blog

    Robots in Healthcare.

  • Blog

    How EHR and EMR Providers are Helping Mankind.

  • Blog

    Fractional Flow Reserve (FFR) is an ideal tool for cardiologists to make the right decision: Dr Nils P Johnson

Popular Post

  • What Components Constitute an Electronic Health Record? What Components Constitute an Electronic Health Record? 20 views
  • Major Role of Stakeholders in E-Prescribing Software. Major Role of Stakeholders in E-Prescribing Software. 9 views
  • Why Electronic Health Records Software Will Continue to Improve in 2021. Why Electronic Health Records Software Will Continue to Improve in 2021. 7 views
  • What is the importance of a Personal Health Record (PHR)? What is the importance of a Personal Health Record (PHR)? 6 views
  • Personal Health Records Software Helps to Manage Your Health between Visits. Personal Health Records Software Helps to Manage Your Health between Visits. 6 views

75Health Video

Email Subscribers

Email *

Interested?

Demo Video
Private cloud
White labeling
Partnership

Services

Electronic Health Records
Electronic Medical Records
Personal Health Records
Practice Management Software
EHR and EMR Providers

Company

About us
Contact us
Terms
Privacy Policy
Sitemap

Address

USA
77 Stonebrae Rd
Hayward CA 94542
India
147, Rajiv Ganghi Salai, OMR,
Elcot Sez, Sholinganallur,
Chennai, Tamil Nadu 600119.

   +1-415-877-3032          +91-95666-74450
© 2020 www.75Health.com. All Rights Reserved.